Essential Fatty Acids: A Potential Solution for Post-COVID-19 Long-Haul Manifestations

This blog was written by Undurti N. Das. Prof. Das is a clinical immunologist, endocrinologist and the founder president and chief executive officer of UND Life Sciences.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

The aftermath of COVID-19 continues to unveil various challenges, with a significant number of individuals experiencing prolonged symptoms even after recovering from the acute phase of the illness. Commonly referred to as "long-haul syndrome," these lingering manifestations encompass a spectrum of issues ranging from fatigue to neurological impairments, posing significant hurdles to recovery [1, 2]. Although several hypotheses have attempted to elucidate the underlying mechanisms, there remains a critical gap in understanding why these symptoms persist and how best to address them [2, 3].

The Role of Essential Fatty Acids (EFAs) in Post-COVID-19 Management

In a recent study by Undurti N. Das published in Lipids in Health and Disease, a compelling hypothesis was proposed regarding the potential role of essential fatty acids (EFAs) in preventing and alleviating post-COVID-19 long-haul manifestations [4]. Das suggested that deficiencies in EFAs and dysregulation of their metabolism may contribute to the development and persistence of symptoms associated with long-haul syndrome [4].

Understanding the Hypothesis

Das's hypothesis stems from the multifaceted roles EFAs play in modulating various physiological processes, particularly those relevant to the immune response and tissue homeostasis [4]. EFAs and their metabolites exhibit immunomodulatory properties, influencing the host's response to viral infections such as SARS-CoV-2 [4]. These compounds have been shown to regulate cytokine release, exert cytoprotective effects, modulate neurotransmitter production, inhibit inflammatory pathways, and promote tissue repair and regeneration [4].

Implications for Post-COVID-19 Recovery

Considering the broad spectrum of actions attributed to EFAs, their administration may hold promise for mitigating the symptoms of long-haul syndrome and promoting recovery in individuals recovering from COVID-19 [4]. By addressing underlying deficiencies and supporting essential physiological processes, EFAs could alleviate fatigue, cognitive impairments, cardiac complications, and other persistent symptoms associated with long-haul syndrome [4].

Conclusion

The hypothesis put forth by Das underscores the importance of exploring novel approaches to address the complex challenges posed by post-COVID-19 long-term manifestations. Although further research is needed to validate these findings and elucidate the mechanisms involved, the potential role of EFAs in post-COVID-19 management offers a glimmer of hope for individuals experiencing persistent symptoms.

References:

Das UN. Can essential fatty acids (EFAs) prevent and ameliorate post-COVID-19 long haul manifestations? Lipids in Health and Disease. 2024; 23: 112.

National Institutes of Health. Post-Acute Sequelae of SARS-CoV-2 infection (PASC) [Internet]. Available from: https://www.nih.gov/research-training/medical-research-initiatives/pasc

Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324(6): 603–605.

Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021; 27(4): 626-631.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

COVID19
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Infectious Diseases > COVID19
Diseases
Life Sciences > Health Sciences > Clinical Medicine > Diseases
Health Promotion and Disease Prevention
Life Sciences > Health Sciences > Public Health > Health Promotion and Disease Prevention
Fatty Acids
Life Sciences > Biological Sciences > Chemical Biology > Lipidology > Lipids > Fatty Acids

Related Collections

With collections, you can get published faster and increase your visibility.

Lipids and Women’s Health

In this Collection we aim to explore two thematic areas: Lipids in Reproductive Diseases in Women and Influence of Gender Bias on Recent Lipid Studies.

Lipids in Reproductive Diseases in Women

Lipids play a crucial role in the pathophysiology of reproductive diseases in women, serving as key modulators of hormonal balance, inflammation and cellular signaling pathways. This Collection will investigate the complex relationship between lipids and reproductive health, examining their impact on conditions such as polycystic ovary syndrome (PCOS), endometriosis, and infertility. Recent research has provided valuable insights into how lipid metabolism affects women’s reproductive physiology, from dyslipidemia-associated comorbidities to the role of lipid mediators in modulating reproductive tissue function. This Collection aims to pave the way for novel therapeutic intervention and personalized approaches to women’s health.

Influence of Gender Bias on Recent Lipid Studies

Recent advancement in lipids and women’s health research have shed light on the intricate interplay between lipid metabolism and various disease states. However, the influence of gender bias continues to shape lipid research in women’s health. This Collection aims to dissect the impact of gender bias on recent lipid studies. From underrepresentation of women in lipid research cohorts to gender disparities in the evaluation and management of lipid-related diseases, such as cardiovascular disease and metabolic syndrome, sexual bias poses a threat to our understanding of lipid metabolism and its implications for women’s health. By promoting a more equitable and inclusive approach to lipid research, this edition aims to improve our ability to prevent, diagnose, and treat lipid-related diseases in women.

We welcome articles including original articles, systematic reviews, and meta-analyses on these two thematic areas.

Keywords: lipid metabolism, women’s health, reproductive diseases, lipid-related diseases

The topics of interest include but not limited to:

• Understanding the role of lipids in reproductive health and disease in women.

• Understanding of sex-specific differences in lipid-related diseases pathogenesis.

• The development of novel therapeutic interventions targeting lipid metabolism and signaling pathways for the treatment of reproductive diseases and lipid-related diseases and associated comorbidities in women.

• Lipidomics and metabolomics approaches in understanding reproductive diseases in women.

• Epigenetic regulation of lipid metabolism in reproductive diseases.

• Role of gut microbiota and its metabolites in modulating lipid metabolism in metabolic and reproductive function.

• Impact of dietary lipids on metabolic and reproductive health outcomes in women.

Questions to be answered:

• How do lipids contribute to the pathophysiology of reproductive diseases in women?

• What are the mechanisms by which dyslipidemia affects hormonal balance, inflammation, and cellular signaling pathways in women's reproductive health?

• How do lipid mediators modulate the function of reproductive tissues, and what implications does this have for disease development and progression?

• What sex-specific differences exist in the pathogenesis of lipid-related diseases, and how do these differences influence disease presentation, diagnosis, and treatment in women?

All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: May 31, 2025

Environmental Exposures and Lipid Homeostasis: Investigating the Impact of Pollutants on Metabolic Health

Lipid homeostasis involves maintaining a balance between lipid synthesis, storage, and utilization in the body. Coordination among various organs, including the liver, kidney, cardiovascular system, and adipose tissues, is needed. Dysregulation of lipid homeostasis has been shown to lead to the development of metabolic disorders, including obesity, diabetes, and cardiovascular disease, which are major health concerns worldwide.

Humans are exposed to various environmental pollutants, such as air pollutants, heavy metals, and persistent organic pollutants (POPs), as well as climate-related factors. Repeated and prolonged exposure to these factors may contribute to alterations in lipid homeostasis. However, how environmental exposures affect lipid homeostasis, including which groups are most vulnerable and the critical exposure windows is incompletely understood.

This Collection focuses on the link between environmental factors and lipid homeostasis. Understanding the role of these risk factors is essential for developing effective prevention strategies, especially those targeted at vulnerable population subgroups, and promoting policies aimed at limiting environmental release.

We welcome original research and (systematic) review articles, comments, and brief reports. Manuscripts on epidemiological, toxicological, and controlled human exposure studies will equally be accepted.

The collection may include, but is not limited to, the following topics:

• Associations between environmental factors (climate-related hazards or pollutants) and changes in clinical lipid markers

• Associations between environmental factors and changes in lipid metabolites or other associated metabolites and corresponding molecular, cellular, and systemic mechanisms

• Novel approaches to examine the exposome (internal or external) framework and multipollutant mixtures and their impact on lipid homeostasis.

Keywords: Environmental exposures, lipid homeostasis, metabolic diseases, pollutants, toxins, therapeutic strategies

This Collection supports and amplifies research related to SDG 3, Good Health and Well-Being.

All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: Apr 15, 2025